These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 93730)

  • 1. Presynaptic localization of substance P degradative enzymes(s) in rat substantia nigra.
    Quik M; Emson PC
    Neurosci Lett; 1979 Dec; 15(2-3):217-22. PubMed ID: 93730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dissociation between the presynaptic dopamine-sensitive adenylate cyclase and [3H]spiperone binding sites in rat substantia nigra.
    Quik M; Emson PC; Joyce E
    Brain Res; 1979 May; 167(2):355-65. PubMed ID: 36204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopamine-sensitive adenylate cyclase: location in substantia nigra.
    Gale K; Guidotti A; Costa E
    Science; 1977 Feb; 195(4277):503-5. PubMed ID: 13499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nigrostriatal dopamine neurons receive substance P-ergic inputs in the substantia nigra: application of the immunoelectron microscopic mirror technique to fluorescent double-staining for transmitter-specific projections.
    Kawai Y; Takagi H; Kumoi Y; Shiosaka S; Tohyama M
    Brain Res; 1987 Jan; 401(2):371-6. PubMed ID: 2434194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nigrostriatal dopamine neurons are required to maintain basal levels of substance P in the rat substantia nigra.
    Cruz CJ; Beckstead RM
    Neuroscience; 1989; 30(2):331-8. PubMed ID: 2473415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of neurotensin-containing neurons in the rat striatum and substantia nigra. Effects of unilateral nigral lesion with 6-hydroxydopamine on neurotensin content and its binding site density.
    Masuo Y; Pélaprat D; Montagne MN; Scherman D; Rostène W
    Brain Res; 1990 Mar; 510(2):203-10. PubMed ID: 1970504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Axonal transport of proteins and glycoproteins in the rat nigro-striatal pathway and the effects of 6-hydroxydopamine.
    Roger LJ; Breese GR; Morell P
    Brain Res; 1980 Sep; 197(1):95-112. PubMed ID: 6156743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential anatomical location of [3H]-N,n-propylnorapomorphine and [3H]-spiperone binding sites in the striatum and substantia nigra of the rat.
    Hall MD; Jenner P; Kelly E; Marsden CD
    Br J Pharmacol; 1983 Jun; 79(2):599-610. PubMed ID: 6418246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The localization of receptor binding sites in the substantia nigra and striatum of the rat.
    Reisine TD; Nagy JI; Beaumont K; Fibiger HC; Yamamura HI
    Brain Res; 1979 Nov; 177(2):241-52. PubMed ID: 227532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topographic projections of substance P and GABA pathways in the striato- and pallido-nigral system: a biochemical and immunohistochemical study.
    Jessell TM; Emson PC; Paxinos G; Cuello AC
    Brain Res; 1978 Sep; 152(3):487-98. PubMed ID: 356929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence that [3H]dopamine is taken up and released from nondopaminergic nerve terminals in the rat substantia nigra in vitro.
    Kelly E; Jenner P; Marsden CD
    J Neurochem; 1985 Jul; 45(1):137-44. PubMed ID: 3923157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Degeneration of the nigral dopamine neurons after 6-hydroxydopamine injection into the rat striatum.
    Ichitani Y; Okamura H; Matsumoto Y; Nagatsu I; Ibata Y
    Brain Res; 1991 May; 549(2):350-3. PubMed ID: 1679369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct demonstration of interactions between substance P immunoreactive terminals and tyrosine hydroxylase immunoreactive neurons in the substantia nigra of the rat: an ultrastructural study.
    Mahalik TJ
    Synapse; 1988; 2(5):508-15. PubMed ID: 2460962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopaminergic innervation of substance P-containing striatal neurons by fetal nigral grafts: an ultrastructural double-labeling immunocytochemical study.
    Mendez I; Elisevich K; Flumerfelt B
    J Comp Neurol; 1991 Jun; 308(1):66-78. PubMed ID: 1714923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence concerning the anatomical location of the dopamine stimulated adenylate cyclase in the substantia nigra.
    Phillipson OT; Emson PC; Horn AS; Jessell T
    Brain Res; 1977 Nov; 136(1):45-58. PubMed ID: 22389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Localization of striatal and nigral tachykinin receptors in the rat.
    Stoessl AJ
    Brain Res; 1994 May; 646(1):13-8. PubMed ID: 7519961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of kainic acid in the localization of enzymes in the substantia nigra.
    Nagy JI; Vincent SR; Lehmann J; Fibiger HC; McGeer EG
    Brain Res; 1978 Jun; 149(2):431-41. PubMed ID: 27284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of kainic acid injections and other brain lesions on vasoactive intestinal peptide (VIP)-stimulated formation of cAMP in rat brain.
    Quik M; Emson PC; Fahrenkrug J; Iversen LL
    Naunyn Schmiedebergs Arch Pharmacol; 1979 Apr; 306(3):281-6. PubMed ID: 38409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specificity of dopaminergic neuronal degeneration induced by intracerebral injection of 6-hydroxydopamine in the nigrostriatal dopamine system.
    Javoy F; Sotelo C; Herbet A; Agid Y
    Brain Res; 1976 Feb; 102(2):201-15. PubMed ID: 1247882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin-converting enzyme in substantia nigra: reduction of activity in Huntington's disease and after intrastriatal kainic acid in rats.
    Arregui A; Emson PC; Spokes EG
    Eur J Pharmacol; 1978 Nov; 52(1):121-4. PubMed ID: 214307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.